Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: an open-label randomized clinical trial
PaperCitations, authors & open-access status
Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: an open-label randomized clinical trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 48 citations, 2023 year and gold oa status.
48
Citations
2023
Year
gold
OA Status